Hap Trading, LLC Mustang Bio, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.58 - $1.13 $5,916 - $11,525	-10,200 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.73 - $1.81 $146 - $362	-200 Reduced 1.92%	10,200 $0
Q4 2021 Feb 14, 2022	BUY	$1.66 - $2.64 $17,264 - $27,456	10,400 New	10,400 $1,000
Q3 2021 Nov 10, 2021	SELL	$2.58 - $3.36 $52,374 - $68,208	-20,300 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.7 - $3.81 $1,080 - $1,524	-400 Reduced 1.93%	20,300 $5,000
Q1 2021 May 14, 2021	BUY	$3.02 - $5.16 $7,852 - $13,416	2,600 Added 14.36%	20,700 $4,000
Q4 2020 Feb 16, 2021	SELL	$2.66 - $4.18 $6,118 - $9,614	-2,300 Reduced 11.27%	18,100 $14,000
Q3 2020 Nov 13, 2020	BUY	$3.01 - $3.88 $61,403 - $79,152	20,400 New	20,400 $12,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $24.2M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.